GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camp4 Therapeutics Corp (NAS:CAMP) » Definitions » Return-on-Tangible-Asset

CAMP (Camp4 Therapeutics) Return-on-Tangible-Asset : -70.50% (As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Camp4 Therapeutics Return-on-Tangible-Asset?

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Camp4 Therapeutics's annualized Net Income for the quarter that ended in Mar. 2025 was $-49.73 Mil. Camp4 Therapeutics's average total tangible assets for the quarter that ended in Mar. 2025 was $70.54 Mil. Therefore, Camp4 Therapeutics's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 was -70.50%.

The historical rank and industry rank for Camp4 Therapeutics's Return-on-Tangible-Asset or its related term are showing as below:

CAMP' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -107.64   Med: -62.59   Max: -43.09
Current: -107.64

During the past 3 years, Camp4 Therapeutics's highest Return-on-Tangible-Asset was -43.09%. The lowest was -107.64%. And the median was -62.59%.

CAMP's Return-on-Tangible-Asset is ranked worse than
80.51% of 1498 companies
in the Biotechnology industry
Industry Median: -36.17 vs CAMP: -107.64

Camp4 Therapeutics Return-on-Tangible-Asset Historical Data

The historical data trend for Camp4 Therapeutics's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camp4 Therapeutics Return-on-Tangible-Asset Chart

Camp4 Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Return-on-Tangible-Asset
-43.09 -62.59 -77.73

Camp4 Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Return-on-Tangible-Asset Get a 7-Day Free Trial -90.65 -167.99 -210.24 -106.58 -70.50

Competitive Comparison of Camp4 Therapeutics's Return-on-Tangible-Asset

For the Biotechnology subindustry, Camp4 Therapeutics's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camp4 Therapeutics's Return-on-Tangible-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camp4 Therapeutics's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Camp4 Therapeutics's Return-on-Tangible-Asset falls into.


;
;

Camp4 Therapeutics Return-on-Tangible-Asset Calculation

Camp4 Therapeutics's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2024 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2024 )  (A: Dec. 2023 )(A: Dec. 2024 )
=-51.791/( (54.946+78.307)/ 2 )
=-51.791/66.6265
=-77.73 %

Camp4 Therapeutics's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Mar. 2025 )  (Q: Dec. 2024 )(Q: Mar. 2025 )
=-49.732/( (78.307+62.773)/ 2 )
=-49.732/70.54
=-70.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Mar. 2025) net income data.


Camp4 Therapeutics  (NAS:CAMP) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Camp4 Therapeutics Return-on-Tangible-Asset Related Terms

Thank you for viewing the detailed overview of Camp4 Therapeutics's Return-on-Tangible-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Camp4 Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA, USA
Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.